Loading...
Found 610 iu-health-enterprise-system trials
A listing of iu-health-enterprise-system medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
A
April Savoy
For patients and caregivers, ADRD-DM presents unique challenges for detecting and preventing hypoglycemia.Individualized care for people with ADRD-DM should be based on patient and caregiver goals along with patients’ cognitive and physical abilities, reported outcomes, and hypoglycemia risk, based largely on prior hypoglycemic events. Providing details of hypoglycemic events and risks …
B
Bryan Schneider, MD
This study investigates treatments for patients with residual triple negative breast cancer, a type of breast cancer that does not have estrogen, progesterone, or HER2 receptors. The study uses circulating tumor DNA (ctDNA) to assign participants to different treatment arms based on their genomic markers. Participants with ctDNA positivity and …
S
Sandeep Batra, MD
This study investigates treatment options for children and young adults with low-grade glioma (LGG), a type of brain tumor. The purpose of this study is to compare the effects of an investigational medication with standard chemotherapy treatments, carboplatin and vincristine, in patients who do not have a specific genetic mutation …
J
Jordan Holmes
This study investigates how completing surveys about symptoms and quality of life during radiation treatment affects symptom management. The focus is on patients who speak English or Spanish and are undergoing treatment for certain cancers, like endometrial, cervical, or prostate cancer. The goal is to see if real-time feedback can …
N
Nasser Hanna, MD
This study investigates the use of circulating tumor DNA (ctDNA) to personalize treatment for patients with stage III non-small cell lung cancer (NSCLC). The purpose is to use ctDNA analysis to guide therapy decisions, instead of relying solely on clinical or radiographic evidence of disease. This approach aims to tailor …
T
Tarah Ballinger, MD
This study investigates how genetic ancestry affects the completion of treatment in patients diagnosed with breast cancer. Breast cancer is a disease where cells in the breast grow out of control. This study involves newly diagnosed women with stages I-III breast cancer who self-report as Black or White.Participants will provide …
A
Anthony Ross
This study investigates an investigational medication for treating Langerhans cell histiocytosis (LCH), a disease where the body makes too many immature Langerhans cells, a type of white blood cell. These cells can build up and form tumors in organs like bones, skin, and lungs, causing damage. The purpose of the …
J
Jared Brosch, MD
What is the purpose of this study?To assess the safety, tolerability, biomarker, cognitive, and clinical efficacy of investigational products in participants with an Alzheimer's disease-causing mutation by determining if treatment with the study drug improves disease-related biomarkers and slows the rate of progression of cognitive or clinical impairment.THIS STUDY IS …
A
Archita Desai, MD
This study investigates the use of the Cirrhosis Risk Instrument for Stratifying Post Emergency Department mortality (CRISPE) tool in individuals with cirrhosis. Cirrhosis is a condition where the liver becomes scarred and its function is impaired. The purpose of this study is to validate the CRISPE tool prospectively to predict …
R
Rachael Schulte
This study investigates a treatment for PIK3CA Related Overgrowth Spectrum (PROS), a condition caused by a mutation in the PIK3CA gene that leads to abnormal growths in the body. The purpose of this study is to evaluate the safety and effectiveness of an investigational medication targeting these mutations.Participants in this …
Please choose between Voice or SMS based delivery of verification code
or